Biosimilars could generate savings of about $116 million in New Jersey annually—including the state’s Medicaid program and patients with commercial insurance, according to a new issue brief by the Center for Medical Economics and Innovation at the Pacific Research Institute. Nationwide, those annual savings could reach $7 billion.

A panel of speakers from Horizon BCBSNJ, AmplaPay, RWJBarnanbas Health, OculoMotor Technologies and Quest Diagnostics discussed new opportunities for providers, insurers and entrepreneurs during the How Technology is Changing Health Care event presented by Newark Regional Business Partnership on Nov. 7.

Despite significant increases in enrollment nationwide over the past decade, Clover Health revealed that just 27 percent of Garden State seniors are enrolled in a MA plan.

At the end of October, CentraState and KDC Solar completed work giving the medical center the distinction of having the largest solar installation, for such an institution, in New Jersey.

The agreement adds 27 primary care doctors to HMO and PPO members in Bergen County.

According to the medical center, it is the first telemedicine transitional care platform in the United States with Telemedicine911 patient safety.

Communities from across the state will participate in the 11th annual American Medicine Chest Challenge – New Jersey Day of Awareness of Prescription Drug Abuse and Safe Disposal, a public health initiative from the Partnership for a Drug-Free New Jersey designed to help raise awareness about the dangers of prescription drug abuse.

Reg Grant will serve as director of human performance to develop and launch a new medical fitness program.

U.S. Rep. Donald Norcross joined South Jersey health care providers, health care recipients and community leaders at the Cherry Hill Free Health Care Clinic to discuss the need for affordable, quality health care.

These institutions include national and regional health systems and some of the largest private-sector employers in their states and regions.

According to Leapfrog, 55 of 69 hospitals graded received an A or B grade (80 percent) – 5.6 percent lower than last round.

Rutgers Biomedical and Health Sciences Chancellor Brian Strom is leading an investigation of the co-prescription of the drugs as it relates to veteran overdoses and deaths.